CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | SCHMERTZLER MICHAEL Director | Grant or award | +8,000 | 123,266 | ||
| 2024-02-15 | SCHMERTZLER MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2024-02-15 | Bell William F. Jr. Director | Grant or award | +4,000 | 10,333 | ||
| 2024-02-15 | Bell William F. Jr. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-02-15 | SOUTHWELL DAVID P Director | Grant or award | +4,000 | 14,500 | ||
| 2024-02-15 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-02-15 | Okey Stephanie Director | Grant or award | +4,000 | 9,867 | ||
| 2024-02-15 | Okey Stephanie Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-02-15 | Gravier Pierre CHIEF FINANCIAL OFFICER | Grant or award | +19,000 | 52,700 | ||
| 2024-02-15 | Gravier Pierre CHIEF FINANCIAL OFFICER | Grant or award | +3,100 | 55,800 | ||
| 2024-02-15 | Gravier Pierre CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +47,500 | 47,500 | ||
| 2024-02-15 | Golden Lee Scott CHIEF MEDICAL OFFICER | Grant or award | +20,000 | 57,914 | ||
| 2024-02-15 | Golden Lee Scott CHIEF MEDICAL OFFICER | Grant or award | +2,600 | 60,514 | ||
| 2024-02-15 | Golden Lee Scott CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-02-15 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award | +70,000 | 230,475 | ||
| 2024-02-15 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2024-02-15 | Boulding Mark Elliott EXEC. VP AND CLO | Grant or award | +18,000 | 89,189 | ||
| 2024-02-15 | Boulding Mark Elliott EXEC. VP AND CLO | Grant or award | +3,200 | 92,389 | ||
| 2024-02-15 | Boulding Mark Elliott EXEC. VP AND CLO | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-02-15 | Jacobson Allan Steven Director | Grant or award | +4,000 | 16,348 |
Page 34 of 41 · 804 trades